Stay updated on Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study's location information was reorganized under a new Locations section with California and Oregon listed within it, replacing the previous separate California Locations and Oregon Locations sections. The revision number was updated to v3.3.3 and the HHS Vulnerability Disclosure footer was removed.
    Difference
    0.3%
    Check dated 2025-12-23T07:42:46.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page footer now displays 'Revision: v3.3.2' and removes 'Revision: v3.3.1'—a minor administrative change that does not affect the study data, eligibility criteria, or scheduling. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T15:59:07.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The Publications section now notes that PubMed publications are automatically filled and may not be about the study, and the page revision is updated to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T12:43:25.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The government funding status notice at the top of the page was removed, with no impact on the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:24:20.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    No changes detected in core study information such as eligibility criteria, interventions, outcomes, enrollment, or study status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:00:14.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T10:04:36.000Z thumbnail image

Stay in the know with updates to Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemo Plus Pembrolizumab in Breast Cancer Clinical Trial page.